"Our analysis does not provide absolute proof that glargine promotes cancer," says Peter T. Sawicki, IQWiG's Director and co-author of the study. "Our study does, however, arouse an urgent suspicion which should have consequences for the treatment of patients."
One wonders if these are the same type of "consequences" Nissen raised for AVANDIA ..... only for us to hear, two years later, that studies override those "findings" after the drug's reputation is damaged, probably beyond repair.
One wonders if these are the same type of "consequences" Nissen raised for AVANDIA ..... only for us to hear, two years later, that studies override those "findings" after the drug's reputation is damaged, probably beyond repair.
Read the full Science Daily articlehere.